Sanofi Allegra Switch Approval Triggers Race To Market For Perrigo
This article was originally published in The Tan Sheet
Executive Summary
Sanofi-Aventis will launch nonprescription Allegra allergy relief products March 4, but the line might not beat private-label fexofenadine products to store shelves.